1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Extension Study for the Port Delivery System With Ranibizumab (Portal)Neovascular Age-Related Macular DegenerationRecruitingPhase 32026-09-28NCT03683251